BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9145566)

  • 1. Monitoring anticoagulant therapy by measuring haemostatic parameters.
    Chek JB
    East Afr Med J; 1997 Jan; 74(1):1-2. PubMed ID: 9145566
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prescription and monitoring of anticoagulant therapies].
    Laviolle B; Oger E
    Rev Prat; 2008 Nov; 58(18):2063-70. PubMed ID: 19143281
    [No Abstract]   [Full Text] [Related]  

  • 3. Practice guidelines for reversal of new and old anticoagulants.
    Hartman SK; Teruya J
    Dis Mon; 2012 Aug; 58(8):448-61. PubMed ID: 22818559
    [No Abstract]   [Full Text] [Related]  

  • 4. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: introduction.
    Brandt JT
    Arch Pathol Lab Med; 1998 Sep; 122(9):765-6. PubMed ID: 9740134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monitoring of coagulation during treatment with direct oral anticoagulants].
    Kasper A; Lindhoff-Last E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1997-2000. PubMed ID: 24065404
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendation for the introduction of the International Normalized Ratio as an objective measure for the dosage of oral anticoagulant therapy].
    Horstkotte D; Hohnloser S; Keller F; Kolde HJ; Müller-Beissenhirtz W; Taborski U; Webering F
    Z Kardiol; 1994 Sep; 83(9):676-9. PubMed ID: 7801672
    [No Abstract]   [Full Text] [Related]  

  • 7. Ximelagatran, a new oral anticoagulant--how will it affect laboratory practice? A laboratory perspective.
    Kottke-Marchant K
    Lab Hematol; 2004; 10(3):173-5. PubMed ID: 15529440
    [No Abstract]   [Full Text] [Related]  

  • 8. Ximelagatran, a new oral anticoagulant--how will it affect laboratory practice? A clinical perspective.
    Machin SJ
    Lab Hematol; 2004; 10(3):172-3. PubMed ID: 15529439
    [No Abstract]   [Full Text] [Related]  

  • 9. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
    Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
    Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient self-management of oral anticoagulation.
    Fancher TL; White RH
    Curr Hematol Rep; 2004 Sep; 3(5):368-74. PubMed ID: 15341705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring of oral anticoagulant therapy in Norway--recommendations for transfer to the INR system].
    Sandset PM
    Tidsskr Nor Laegeforen; 1998 Sep; 118(22):3443-5. PubMed ID: 9800495
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
    Casimire T; Carter R; Peters S; Tweedle J; Charles KS
    Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory tests during direct oral anticoagulant treatment? Authors' reply.
    Di Minno G; Ricciardi E; Scalera A
    Intern Emerg Med; 2015 Jun; 10(4):533-4. PubMed ID: 26089255
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient management of patients on warfarin.
    Beckey NP
    Lippincotts Prim Care Pract; 1999; 3(3):280-9. PubMed ID: 10711130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assessment in point-of-care coagulation testing.
    Kitchen DP; Kitchen S; Jennings I; Woods T; Walker I
    Semin Thromb Hemost; 2008 Oct; 34(7):647-53. PubMed ID: 19085765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different sensitivities of various thromboplastins to two blood collection systems for monitoring oral anticoagulant therapy.
    van den Besselaar AM; Bertina RM; van der Meer FJ; den Hartigh J
    Thromb Haemost; 1999 Jul; 82(1):153-4. PubMed ID: 10456474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.